A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213

S. H. Bernstein, E. Epner, J. M. Unger, M. LeBlanc, E. Cebula, R. Burack, L. Rimsza, T. P. Miller, R. I. Fisher

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213'. Together they form a unique fingerprint.

Medicine & Life Sciences